Open access
4,467
Views
61
CrossRef citations to date
0
Altmetric
Report
Discovery and characterization of olokizumab
A humanized antibody targeting interleukin-6 and neutralizing gp130-signaling
Stevan Shaw UCB Pharma; Berkshire, UK
, Tim Bourne UCB Pharma; Berkshire, UK
, Chris Meier UCB Pharma; Berkshire, UK
, Bruce Carrington UCB Pharma; Berkshire, UK
, Rich Gelinas Institute for Systems Biology; Seattle, WA USA
, Alistair Henry UCB Pharma; Berkshire, UK
, Andrew Popplewell UCB Pharma; Berkshire, UK
, Ralph Adams UCB Pharma; Berkshire, UK
, Terry Baker UCB Pharma; Berkshire, UK
, Steve Rapecki UCB Pharma; Berkshire, UK
, Diane Marshall UCB Pharma; Berkshire, UK
, Adrian Moore UCB Pharma; Berkshire, UK
, Helen Neale UCB Pharma; Berkshire, UK
& Alastair Lawson UCB Pharma; Berkshire, UKCorrespondence[email protected]
show all
Pages 773-781
|
Received 27 Jan 2014, Accepted 20 Mar 2014, Published online: 02 Apr 2014
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.